Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dermatology
Fierce Pharma
JPM26: Leo Pharma sharpens its eye for dermatology dealmaking
Leo Pharma CEO Christophe Bourdon is eager to make additional strides on the new era of growth he’s fostered since taking over in 2022.
Zoey Becker
Jan 13, 2026 2:45pm
Novartis pens $1.7B atopic disease pact with British biotech
Dec 9, 2025 3:57am
Sirona closes R&D labs as Allergan deal, financing plans crumble
Aug 4, 2025 7:55am
Quoin shelves 2 assets to build around lead program
Jul 29, 2025 10:25am
Novartis' ianalumab fails to show promise in dermatology study
Jul 17, 2025 4:28am
Kaken pens $180M pact for Alumis' lead TYK2 inhibitor in Japan
Mar 25, 2025 6:55am
